Blog & Earnings Analysis

Stock Earnings Analysis

AI-powered earnings analysis with management quotes, bull/bear cases, and financial breakdowns for 400+ public companies.

GSK7 min read

GSK Delivers a Dose of Growth with $8.5B Cure for Doubts

GSK's earnings surge and resilient pipeline provide hope despite looming HIV headwinds.

JCI7 min read

JCI Stays in Control with $5.8B Revenue Rev-Up

Johnson Controls shows strength with solid growth, but the sustainability debate may leave investors feeling a bit chilled.

LLY8 min read

The Obesity Battle Ramps Up with $19.3B Boost

Eli Lilly flexes its muscles with a 42.6% revenue jump, but can it dodge pricing pressures ahead?

MET7 min read

MetLife's Revenue Rises 29% While Its Stock Takes a Stumble

With rising revenue but falling stock, MetLife faces a tightrope walk on sustainability and growth.

MKL7 min read

Markel's Earnings Team Scores with $4.2B Play

Markel demonstrates resilience, but can they keep the win streak alive amid softening markets?

NVS8 min read

Novartis Stirs Up a 2% Rise Despite $13.3B Liver Logic

With mixed signals on Remibrutinib, can Novartis balance growth and trial turbulence?

ORLY8 min read

Revving Up with $4.4B but Stalling at -2.6%

O'Reilly’s growth clashes with rising costs, leaving investors in the slow lane of uncertainty.

PSX7 min read

Refining Success Fuels 4.5% Surge for Phillips 66

With revenue at $34.1B, PSX shines but bears brace for sustainability questions.

PTC9 min read

PTC's Revenue Lifecycle Hits a High Note at $686M

As PTC thrives on smart product innovation, the challenge of deferred ARR looms large.

QCOM7 min read

Chip Woes Dampen Qualcomm's $12.3B Signal

Qualcomm's earnings show growth, but DRAM shortages put a serious dent in the handset horizon.

SNAP9 min read

Snap Out of It With $1.7B and 13.4% Drop

Snap's earnings reveal a struggle between growth and profit, leaving investors in a state of snap-shock.

SNEX6 min read

Preciously Profitable with $39B in Gold-Plated Growth

StoneX shines bright amid market volatility, but can its dazzling earnings power survive integration hurdles?

SYM8 min read

Symbotic’s 630M Growth Sparks AI-mazing Possibilities

With a 29.4% revenue boost, Symbotic navigates both promise and peril in its quest for AI-driven success.

UBER8 min read

Uber Takes a Detour with $14.4B Revenue and 5.1% Drop

Despite strong revenue growth, fears of AV roadblocks leave Uber's stock spinning its wheels.

ADM8 min read

Crushing Expectations or Just Crushing It? $18.6B Down 13.7%

ADM's revenue dip raises questions about biofuel futures and market resilience amid rising costs and demand challenges.

AMD8 min read

AMD’s Earnings Take a 17.3% Chip Off the Old Block

AMD’s Q4 stumble raises questions about its AI ambitions—can it regain momentum before the competition catches up?

AMGN7 min read

Meritide's Magic Lifts Amgen 8.2% to New Heights

Amgen's Q4 earnings show that Meritide is the real heavyweight in the obesity ring, but beware of competitive jabs!

CB8 min read

Chubb's Coverage Claims a 5.7% Gain but Faces Pricing Storms

Chubb's solid growth masks looming pricing pressures and regulatory challenges.

CMG7 min read

Guac and Roll with $3B as Chipotle Stirs Up Debate

With 4.9% growth, Chipotle serves up a spicy mix of optimism and concern for the year ahead.

CTVA8 min read

Crop and Drop: Corteva's $3.9B Yield Falls Short

With revenue down and stock sliding, Corteva's harvest of hopes faces tough weather ahead.

ENPH7 min read

Enphase Shines Bright Despite Revenue Clouds at $343M

With a dazzling 38.6% stock surge, can Enphase outsmart the tariff storm?

EPD7 min read

Pipeline to Profit? EPD Rides 4.6% Gain Despite Revenue Dip

EPD's earnings surge masks caution over future growth amidst commodity concerns.

ETN7 min read

Powering Up with $7.1B as Eaton Sparks AI Debate

Eaton's earnings light the fuse on AI growth but execution risks loom large.

INTA8 min read

Intapp-ted Potential? $140M Revenue Faces AI Reality Check

Despite solid growth, Intapp's stock nosedives as AI promise turns into a high-stakes debate over durability and monetization.